Corporate
The Aseptic Business Unit provides complete filling lines for injectable products in ampoules, cartridges, syringes and vials, covering washing, depyrogenation, handling of RTU containers, liquid filling, powder filling, inspection, labeling and end‑of‑line.
In 2025, the Group formed a strategic partnership with AST, a U.S.-based leader in aseptic fill-finish processing technology, headquartered in Tacoma, Washington. The partnership will enable the development of sophisticated technologies, driven by a shared vision: creating value for customers, expanding market presence and fostering innovation.
In 2025, the Group formed a strategic partnership with AST, a U.S.-based leader in aseptic fill-finish processing technology, headquartered in Tacoma, Washington. The partnership will enable the development of sophisticated technologies, driven by a shared vision: creating value for customers, expanding market presence and fostering innovation.
AST leader in aseptic fill‑finish technology, with 60 years of engineering experience, it provides advanced, flexible systems that ensure high sterility, efficiency, and product quality for injectable therapies trusted worldwide. The company pharmaceutical manufacturers to achieve the highest levels of sterility assurance.
AST leader in aseptic fill‑finish technology, with 60 years of engineering experience, it provides advanced, flexible systems that ensure high sterility, efficiency, and product quality for injectable therapies trusted worldwide. The company pharmaceutical manufacturers to achieve the highest levels of sterility assurance.
AST’s advanced aseptic filling and closing technologies for the pharmaceutical and biotech sectors will complement Corima’s sterile filling expertise, CMP Pharma’s inspection systems for ampoules and vials, and MAR’s precision filling and capping solutions for liquid and powder products.